We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+5.99%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.75B
AUM Growth
-$39.4M
Cap. Flow
-$636M
Cap. Flow %
-11.06%
Top 10 Hldgs %
22.09%
Holding
798
New
336
Increased
102
Reduced
128
Closed
170

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$72.3M
2
VYX icon
NCR Voyix
VYX
+$64.1M
3
HUM icon
Humana
HUM
+$64M
4
CNQR
CONCUR TECHNOLOGIES INC
CNQR
+$63.4M
5
TSM icon
TSMC
TSM
+$62.3M

Sector Composition

Rank Sector Weight
1 Healthcare 11.85%
2 Consumer Discretionary 11.63%
3 Consumer Staples 10.69%
4 Industrials 10.3%
5 Technology 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTRA
201
DELISTED
Coterra Energy
CTRA
$3.31M 0.06%
+111,800
New +$3.52M
HAFC icon
202
Hanmi Financial
HAFC
$954M
$3.3M 0.06%
+151,392
New +$3.15M
LTRPA
203
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$3.28M 0.06%
122,083
-523,283
-81% -$14.5M
PCAR icon
204
PACCAR
PCAR
$69.5B
$3.26M 0.06%
+72,000
New +$3.11M
UDR icon
205
UDR
UDR
$12.3B
$3.14M 0.05%
101,927
+11,205
+12% +$336K
HRI icon
206
Herc Holdings
HRI
$5.62B
$3.12M 0.05%
41,667
-513,838
-92% -$34.7M
DMND
207
DELISTED
DIAMOND FOODS, INC.
DMND
$3.1M 0.05%
109,653
+8,575
+8% +$249K
MOBL
208
DELISTED
MobileIron, Inc.
MOBL
$3.08M 0.05%
308,845
+113,200
+58% +$1.07M
LBTYK icon
209
Liberty Global Class C
LBTYK
$3.58B
$3.06M 0.05%
78,202
-123,639
-61% -$4.51M
DOC icon
210
Healthpeak Properties
DOC
$14.5B
$3M 0.05%
74,729
+15,131
+25% +$600K
PE
211
DELISTED
PARSLEY ENERGY INC
PE
$2.98M 0.05%
+186,500
New +$3.02M
FRPT icon
212
Freshpet
FRPT
$3.28B
$2.89M 0.05%
+169,371
New +$2.92M
UMPQ
213
DELISTED
Umpqua Holdings Corp
UMPQ
$2.83M 0.05%
166,567
-113,867
-41% -$1.93M
GGP
214
DELISTED
GGP Inc.
GGP
$2.78M 0.05%
98,947
-21
-0% -$546
RYZ
215
Ryerson Holding Corp
RYZ
$1.4B
$2.76M 0.05%
277,577
+16,217
+6% +$183K
SLB icon
216
SLB Ltd
SLB
$76.5B
$2.72M 0.05%
+31,800
New +$2.93M
SITC icon
217
SITE Centers
SITC
$164M
$2.68M 0.05%
113,306
+15,077
+15% +$348K
ANIP icon
218
ANI Pharmaceuticals
ANIP
$1.88B
$2.64M 0.05%
+46,773
New +$2.06M
CBD
219
DELISTED
Companhia Brasileira de Distribuicao
CBD
$2.58M 0.04%
70,175
+48,179
+219% +$1.95M
OPB
220
DELISTED
Opus Bank Common Stock
OPB
$2.57M 0.04%
90,704
-22,062
-20% -$617K
RDS.A
221
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.47M 0.04%
+39,506
New +$2.55M
GTT
222
DELISTED
GTT Communications, Inc.
GTT
$2.45M 0.04%
+185,500
New +$2.38M
PXD
223
DELISTED
Pioneer Natural Resource Co.
PXD
$2.41M 0.04%
+16,200
New +$2.67M
KEX icon
224
Kirby Corp
KEX
$7.11B
$2.39M 0.04%
29,594
-45,220
-60% -$4.48M
LQD icon
225
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
$2.39M 0.04%
+20,000
New +$2.38M

Similar funds

UBS O'Connor's Q4 2014 Portfolio in Review

As of Q4 2014, UBS O'Connor held 798 positions worth $5.75B, down 0.68% from $5.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

UBS O'Connor withdrew a net $636M in Q4 2014, closing 170 positions and reducing 128 holdings. Its most notable exit was NCR Voyix, an estimated $64.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, UBS O'Connor opened a new position in CAREFUSION CORPORATION worth $129M.

  • UBS O'Connor's largest Q4 2014 buy was CAREFUSION CORPORATION: 2,168,433 shares worth $129M.
  • UBS O'Connor added most to Allergan Inc in Q4 2014, an estimated $71.6M increase.
  • UBS O'Connor's biggest Q4 2014 reduction was Alibaba, cutting an estimated $72.3M.
  • UBS O'Connor fully exited NCR Voyix in Q4 2014, selling an estimated $64.1M.
  • UBS O'Connor's ten largest holdings make up 22% of its $5.75B portfolio in Q4 2014.
  • UBS O'Connor opened 336 new positions and closed 170 in Q4 2014.
  • UBS O'Connor's portfolio value fell 0.68% quarter-over-quarter to $5.75B.

Based on UBS O'Connor's 13F filing for Q4 2014, filed 13 Feb 2015.